Safety and efficacy of contra-lateral breast reduction for women with mammary hypertrophy undergoing mastectomy for breast cancer.
Women with mammary hypertrophy undergoing mastectomy for breast cancer suffer disability because of disproportionate asymmetry. The case notes of all women with mammary hypertrophy undergoing mastectomy and immediate contra-lateral reduction mammaplasty for primary breast cancer from February 2001 to December 2008 were reviewed. Thirty-three women were identified of whom twenty-seven underwent inferior pedicle reduction mammaplasty and six inferior dermoglandular pedicle reduction with free nipple graft. The duration of surgery ranged from 75 to 146 (median 110) minutes. Between 475 and 2350 (median 1090) grams of breast tissue was excised from the contra-lateral breast. No immediate or delayed complications were observed and there were no delays in commencing adjuvant therapy. Immediate contra-lateral breast reduction in women with mammary hypertrophy undergoing mastectomy for breast cancer is safe and effective means of reducing the physical, psychological and cosmetic problems associated with unilateral mammary hypertrophy following mastectomy.
Breast, Endocrine and Surgical Oncology Unit, Royal Adelaide Hospital, Adelaide, Australia.
Michael
M
Green
Sebastian
S
Aspinall
James
J
Kollias
D000368:Aged; D000369:Aged, 80 and over; D015992:Body Mass Index; D001940:Breast / Q000473:pathology*; D001943:Breast Neoplasms / Q000601:surgery*; D005260:Female; D006801:Humans; D006984:Hypertrophy; D016462:Mammaplasty / Q000523:psychology; D008408:Mastectomy; D008875:Middle Aged; D018579:Patient Selection; D012189:Retrospective Studies